Utah Colorado Biotech Networks
Advertise With Biotech Networks
  • Home
  • About
  • News
    • All News
    • UCBN Trending News
  • Jobs
    • All Jobs
    • Submit a Job
  • Advertise
  • BN Connect
    • BN Connect
    • About Biotech Networks Connect
  • Subscribe
  • Contact
News Ticker
  • [ August 21, 2026 ] Part-time Open Rank Research Services Laboratory Services Professional (Entry – Intermediate) (0.5 FTE) – Aurora, CO Jobs
  • [ August 20, 2026 ] Oncology Account Executive – Salt Lake City, UT Jobs
  • [ August 20, 2026 ] Bucked Up® Launches Hunt: Orange Cream, a Limited-Edition Flavor Built to Fuel Your Hunt News
  • [ August 20, 2026 ] New NCCI data analysis confirms Pinnacol Assurance has fastest, most accurate claims handling in Colorado News
  • [ August 20, 2026 ] Engineer 2 – Human Factors – Lakewood, CO Jobs
HomeNewsBioengineering Lab Advances New Approaches to Congenital Heart Surgery

Bioengineering Lab Advances New Approaches to Congenital Heart Surgery

September 1, 2022 UCBN News Comments Off on Bioengineering Lab Advances New Approaches to Congenital Heart Surgery
Bioengineering Lab Advances New Approaches to Congenital Heart Surgery

Jeffrey Jacot, PhD, who oversees the Jacot Lab for Pediatric Regenerative Medicine, easily gets pumped about his work.


Click here to view original post

  • colorado
  • CONews
Previous

Application Engineer (Biomechanics) – Vicon – Englewood, CO

Next

Scientist I CRPM – Steadman Philippon Research Institute – Basalt, CO

Related Articles

News

Residential Care Increases Social Participation But Gaps Remain

August 4, 2025 UCBN News, Syndication Comments Off on Residential Care Increases Social Participation But Gaps Remain

A new study from the University of Colorado Anschutz Medical Campus finds that older adults become more socially active after moving into long-term care communities like nursing homes or assisted living facilities but we might […]

No Picture
News

DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)

February 24, 2025 UCBN News, Syndication Comments Off on DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)

DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025 LITTLETON, Colo., Feb. 24, 2025 /PRNewswire/ — DeFloria, Inc., a collaboration between Ajna BioSciences PBC and Charlotte’s Web Holdings, Inc. (TSX: CWEB, OTCQX: […]

No Picture
News

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder

April 4, 2024 UCBN News, Syndication Comments Off on FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder

Pictured: A scientist works behind an FDA sign/Taylor Tieden for BioSpace The FDA approved 55 new drugs and 34 cell and gene therapies in 2023. But it’s not always good news that companies have to deliver […]

Advertise With Biotech Networks

Copyright © 2026 Biotech Networks

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox